Literature DB >> 2166437

Time course of exercise-induced decline in malonyl-CoA in different muscle types.

W W Winder1, J Arogyasami, I M Elayan, D Cartmill.   

Abstract

Malonyl-CoA is a potent inhibitor of carnitine palmitoyltransferase I (CPT-I), the rate-limiting enzyme for fatty acid oxidation in mitochondria from liver of fed rats. Malonyl-CoA has also been demonstrated to inhibit skeletal muscle CPT-I. This study was designed to determine the rate of decline in malonyl-CoA in muscle during the course of a prolonged exercise bout. Adult male rats were anesthetized (pentobarbital sodium, intravenously) at rest or after running for 5, 10, 20, 30, 60, or 120 min on a treadmill (21 m/min, 15% grade). Malonyl-CoA was then quantitated in the soleus (type I fibers) and in the superficial white (type IIB) and deep red (type IIA) regions of the quadriceps. Malonyl-CoA decreased in red quadriceps from 2.8 +/- 0.2 to 1.4 +/- 0.2 pmol/mg after 5 min and to 0.9 +/- 0.1 pmol/mg after 20 min of exercise. The concentration of malonyl-CoA remained at this level for the duration of the exercise bout (120 min). In white quadriceps, resting values of malonyl-CoA were lower than in red quadriceps, and a significant decline was not observed until 30 min of exercise. A significant decrease in the soleus was observed after 20 min of exercise. This decline in muscle malonyl-CoA may be an important signal for allowing increased fatty acid oxidation during long-term exercise.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2166437     DOI: 10.1152/ajpendo.1990.259.2.E266

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  11 in total

Review 1.  New insights concerning the role of carnitine in the regulation of fuel metabolism in skeletal muscle.

Authors:  Francis B Stephens; Dumitru Constantin-Teodosiu; Paul L Greenhaff
Journal:  J Physiol       Date:  2007-03-01       Impact factor: 5.182

2.  Dynamic changes in fat oxidation in human primary myocytes mirror metabolic characteristics of the donor.

Authors:  Barbara Ukropcova; Michele McNeil; Olga Sereda; Lilian de Jonge; Hui Xie; George A Bray; Steven R Smith
Journal:  J Clin Invest       Date:  2005-07       Impact factor: 14.808

Review 3.  Role of AMPK in skeletal muscle metabolic regulation and adaptation in relation to exercise.

Authors:  Sebastian B Jørgensen; Erik A Richter; Jørgen F P Wojtaszewski
Journal:  J Physiol       Date:  2006-05-11       Impact factor: 5.182

4.  Mitochondrial long chain fatty acid oxidation, fatty acid translocase/CD36 content and carnitine palmitoyltransferase I activity in human skeletal muscle during aerobic exercise.

Authors:  Graham P Holloway; Veronic Bezaire; George J F Heigenhauser; Narendra N Tandon; Jan F C Glatz; Joost J F P Luiken; Arend Bonen; Lawrence L Spriet
Journal:  J Physiol       Date:  2005-12-15       Impact factor: 5.182

5.  Dysregulation of muscle fatty acid metabolism in type 2 diabetes is independent of malonyl-CoA.

Authors:  J A Bell; E Volpi; S Fujita; J G Cadenas; B B Rasmussen
Journal:  Diabetologia       Date:  2006-07-26       Impact factor: 10.122

6.  A rapid up-regulation in UCP3 transcriptional activity in response to moderate intensity exercise in rat skeletal muscle.

Authors:  Keiko Kusuhara; Takashi Tobe; Takaharu Negoro; Takashi Abe
Journal:  J Sports Sci Med       Date:  2005-06-01       Impact factor: 2.988

7.  No effect of insulin treatment or glycemic improvement on plasma carnitine levels in type 2 diabetic patients.

Authors:  P Pregant; E Kaiser; G Schernthaner
Journal:  Clin Investig       Date:  1993-08

8.  Identification of a novel malonyl-CoA IC(50) for CPT-I: implications for predicting in vivo fatty acid oxidation rates.

Authors:  Brennan K Smith; Christopher G R Perry; Timothy R Koves; David C Wright; Jeffrey C Smith; P Darrell Neufer; Deborah M Muoio; Graham P Holloway
Journal:  Biochem J       Date:  2012-11-15       Impact factor: 3.857

Review 9.  Malonyl-CoA and AMP-activated protein kinase: an expanding partnership.

Authors:  Asish K Saha; Neil B Ruderman
Journal:  Mol Cell Biochem       Date:  2003-11       Impact factor: 3.396

10.  Mitochondrial deficiency is associated with insulin resistance.

Authors:  Bret H Goodpaster
Journal:  Diabetes       Date:  2013-04       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.